Aclaris Therapeutics Inc.
ACRS
|
|
| |
|
| Trading Volume | 35,997 |
|
|
8.00 - 0.64 |
| Market Cap Full | $ 83.6M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 4% | 18.1% | -48.6% | 18.6% |
| Q2 | - | -12.3% | 28.2% | -19% |
| Q3 | - | -14.9% | -33.9% | 12.8% |
| Q4 | - | 1.4% | -83.8% | 0.1% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 10.5 | 2.6 | 4.2 | 0.8 | -17.6 | 7.8 | 24.3 | -14.9 | - | - | - | -37.8 |
| 2023 | |||||||||||
| 7.3 | -26.3 | -35.1 | 9.9 | -6.1 | 24.2 | -4.8 | -24.2 | -8.4 | -27.3 | -82.4 | 20 |
| 2022 | |||||||||||
| -24.9 | 36.5 | 15.7 | -28.5 | 3.8 | 9.2 | 10.4 | 3.6 | -1.4 | -0.8 | -2.5 | 3.5 |
| 2021 | |||||||||||
| 220.7 | 8.8 | 6.2 | -0.5 | -6.8 | -21 | -13.6 | 6.9 | 11 | -3.6 | -26.2 | 13.6 |
| 2020 | |||||||||||
| -30 | -13 | -8.8 | 27.9 | 6 | 14.9 | 32.7 | 14.2 | 4.7 | 49.4 | -14.3 | 96.7 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.4 | -0.3 | -0.6 | -0.4 |
| Q2 | -0.4 | -0.3 | -0.3 | -0.3 |
| Q3 | -0.4 | -0.3 | -0.4 | -0.3 |
| Q4 | 0 | -0.4 | -0.3 | -0.3 |
| A | -1.25 | -1.3 | -1.6 | -1.2 |